Oculogenex Information
Contact top employees from
Oculogenex
Summary
Oculogenex is a biopharmaceutical company founded and directed by an ophthalmologist retinal surgeon with patients in mind. It was founded out of passion and frustration shared with patients losing vi...Show more
Organization Website | oculogenex.com |
Social Links |  |
Phone Number | 562-726-4424 |
Industries | |
Headquarters Location | 2250 W Whittier Blvd, La Habra, California, 90631 US |
Employees Size | 1-10 employees |
Specialties | Gene Therapy, Biotechnology, Biopharmaceuticals, Macular Degeneration, Retinal Disease, Ophthalmology, Retina, Drug Delivery |
Founded | 2020 |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2017 | Privately Held | 25 - 100 | 4.5M | $9.4M | |
| 2018 | Privately Held | 1 - 25 | < 1M | $534M | |
| 2020 | - | 10-50 | - | $- |
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at Oculogenex shows a diverse range of experience levels:
20% for 1–2 years60% for 3–4 years20% for 5–7 yearsContact top employees from
Oculogenex
Zhongyang Lu
Senior Scientist, Laboratory Director
Hema Ramkumar
Chief Executive Officer
Ram Ramkumar
Chief Operating Officer
Similar Companies
FAQ
Oculogenex operates in the Biotech industries. More details can be found on the official website: oculogenex.com.
The headquarters of Oculogenex are located in La Habra, United States.
You can contact Oculogenex by phone at 562-726-4424.
Oculogenex currently employs 1-10 people.
Well-known competitors of Oculogenex include Navrogen, Day One Biopharmaceuticals and Comanche Biopharma.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
